Cargando…

Dasatinib reduces 5-Fu-triggered apoptosis in colon carcinoma by directly modulating Src-dependent caspase-9 phosphorylation

Preclinical data have revealed the inhibitory effect of dasatinib on colon cancer. However, a combination of dasatinib and conventional chemotherapy has failed to show any meaningful outcome in a series of clinical trials. We, therefore, wondered whether Src kinase inhibitors were suitable for treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Yang, Yang, Ge, Xue, Peipei, Guo, Luwei, Yin, Yuhan, Ye, Zhiqiang, Peng, Sanfei, Qin, Yanru, Duan, Qiuhong, Zhu, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966379/ https://www.ncbi.nlm.nih.gov/pubmed/29844931 http://dx.doi.org/10.1038/s41420-018-0062-5

Ejemplares similares

Antioxidants decrease the apoptotic effect of 5-Fu in colon cancer by regulating Src-dependent caspase-7 phosphorylation
por: Fu, Y, et al.
Publicado: (2014)

Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon
por: Xiao, Juanjuan, et al.
Publicado: (2016)

Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases
por: Liu, Yuanbo, et al.
Publicado: (2010)

Dasatinib targets c-Src kinase in cardiotoxicity
por: Elmadani, Manar, et al.
Publicado: (2023)

Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling
por: XIAO, JUAN, et al.
Publicado: (2015)

Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer
por: Tian, Qin, et al.
Publicado: (2020)

Tyrosine Phosphorylation of Caspase-8 Abrogates Its Apoptotic Activity and Promotes Activation of c-Src
por: Tsang, Jennifer LY, et al.
Publicado: (2016)

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
por: Algazi, A P, et al.
Publicado: (2012)

Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
por: Perez, Marco, et al.
Publicado: (2016)

Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
por: Perez, Marco, et al.
Publicado: (2016)

Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
por: Eustace, Alex J, et al.
Publicado: (2008)

Small nucleolar RNA host gene 1 promotes development and progression of colorectal cancer through negative regulation of miR‐137
por: Fu, Yang, et al.
Publicado: (2019)

Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)
por: Qian, Xiao-Long, et al.
Publicado: (2017)

Gallic acid suppresses colon cancer proliferation by inhibiting SRC and EGFR phosphorylation
por: Lin, Xiaoming, et al.
Publicado: (2021)

Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib Efficiency
por: Airiau, Kelly, et al.
Publicado: (2018)

UHMK1-dependent phosphorylation of Cajal body protein coilin alters 5-FU sensitivity in colon cancer cells
por: Niu, Huan, et al.
Publicado: (2022)

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
por: van Oosterwijk, J G, et al.
Publicado: (2013)

Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells
por: Dosch, Austin R., et al.
Publicado: (2019)

AGO2 phosphorylation by c-Src kinase promotes tumorigenesis
por: Liu, Tianqi, et al.
Publicado: (2020)

The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
por: Id Boufker, Hichame, et al.
Publicado: (2010)

Dasatinib inhibits primary melanoma cell proliferation through morphology-dependent disruption of Src-ERK signaling
por: WU, JIANGHONG, et al.
Publicado: (2013)

Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells
por: Takiguchi, Eri, et al.
Publicado: (2017)

Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer
por: Hu, Hanqing, et al.
Publicado: (2018)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

HOXC11–SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib
por: deBlacam, C, et al.
Publicado: (2011)

Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model
por: Scott, Aaron J., et al.
Publicado: (2017)

A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma
por: Sun, Jingya, et al.
Publicado: (2018)

Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice
por: Lee, Dajeong, et al.
Publicado: (2020)

FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer
por: Peng, SanFei, et al.
Publicado: (2023)

Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer
por: Mishall, Katie M., et al.
Publicado: (2017)

Monitoring Src status after dasatinib treatment in HER2+ breast cancer with (89)Zr-trastuzumab PET imaging
por: McKnight, Brooke N., et al.
Publicado: (2018)

Phosphorylation of unique domains of Src family kinases
por: Amata, Irene, et al.
Publicado: (2014)

GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS Axis in hepatocellular carcinoma
por: Gu, Yan-jiao, et al.
Publicado: (2015)

Shikonin induces apoptosis and inhibits migration of ovarian carcinoma cells by inhibiting the phosphorylation of Src and FAK
por: HAO, ZHENFENG, et al.
Publicado: (2015)

Purpurin Triggers Caspase-Independent Apoptosis in Candida dubliniensis Biofilms
por: Tsang, Paul Wai-Kei, et al.
Publicado: (2013)

Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells
por: Nautiyal, Jyoti, et al.
Publicado: (2011)

Connexin32 activates necroptosis through Src‐mediated inhibition of caspase 8 in hepatocellular carcinoma
por: Xiang, Yu‐ke, et al.
Publicado: (2021)

Src-mediated caveolin-1 phosphorylation affects the targeting of active Src to specific membrane sites
por: Gottlieb-Abraham, Efrat, et al.
Publicado: (2013)

Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib
por: Klammer, Martin, et al.
Publicado: (2015)

Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma
por: Skoko, Josip, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0remkv22k5h2ecort4pkqkooq5